Dole vs Ingredion
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Dole and Ingredion side by side, using each one’s latest annual report. Here is what stands out:
- Dole is the larger business, with $9.2B of revenue in fiscal 2025 against $7.2B for Ingredion.
- Dole grew revenue faster (8.2%, against −2.8%).
- Ingredion kept more of each dollar of sales as operating profit (14.1% operating margin, against 2.4%).
- Ingredion turned more of its sales into free cash flow (7.1% FCF margin, against 0.0%).
- Ingredion earned a higher return on the capital invested in it (16.0%, against 6.3%).
Who comes out ahead
Of the 11 measures where higher (or lower) is clearly better, how many each company leads.
Dole
DOLE
2/11
Revenue growth5-year growth
Ingredion
INGR
9/11
Gross marginOperating marginNet marginFCF marginReturn on capitalReturn on equityPiotroski F-scoreNet debt / EBITDAShare count change
Side by side
Best in the row
| Latest fiscal year | DOLE FY25 | INGR FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.3B | $6.1B |
| Revenue | $9.2B | $7.2B |
| Free cash flow | $1.7M | $511M |
| Net income | $51.3M | $729M |
| Growth | ||
| Revenue growth | 8.2% | −2.8% |
| 5-year growth | 16.1% | 3.8% |
| Share count change | 0.5% | −2.1% |
| Profitability | ||
| Gross margin | 7.8% | 25.3% |
| Operating margin | 2.4% | 14.1% |
| Net margin | 0.6% | 10.1% |
| FCF margin | 0.0% | 7.1% |
| Return on capital | 6.3% | 16.0% |
| Return on equity | 3.9% | 18.1% |
| Balance sheet | ||
| Net debt | $600M | $709M |
| Net debt / EBITDA | 1.8x | 0.6x |
| Dividends and buybacks | $31.6M | $211M |
| Valuation & quality | ||
| P/E | — | 10.4x |
| Piotroski F-score | 6 | 8 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.